Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20728210

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2010 Aug 28
First author
Bang YJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Oct 16;376(9749):1302
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2010 Aug 28;376(9742):659-60. doi: 10.1016/S0140-6736(10)61022-7.
    note
    Source null
    related pmid
    20728211
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2010 Nov;7(11):611. doi: 10.1038/nrclinonc.2010.161.
    note
    Source null
    related pmid
    21049571
    relationship
    Comment in
  4. citation
    Gastroenterology. 2011 Jan;140(1):356-8; discussion 358. doi: 10.1053/j.gastro.2010.11.011.
    note
    Source null
    related pmid
    21087674
    relationship
    Comment in
  5. citation
    Lancet. 2010 Nov 20;376(9754):1735; author reply 1735-6. doi: 10.1016/S0140-6736(10)62125-3.
    note
    Source null
    related pmid
    21093641
    relationship
    Comment in
  6. citation
    Biomark Med. 2010 Dec;4(6):793.
    note
    Source null
    related pmid
    21174864
    relationship
    Comment in

Authors and identifiers

  1. name
    Bang YJ
    type
    Author
  2. name
    Van Cutsem E
    type
    Author
  3. name
    Feyereislova A
    type
    Author
  4. name
    Chung HC
    type
    Author
  5. name
    Shen L
    type
    Author
  6. name
    Sawaki A
    type
    Author
  7. name
    Lordick F
    type
    Author
  8. name
    Ohtsu A
    type
    Author
  9. name
    Omuro Y
    type
    Author
  10. name
    Satoh T
    type
    Author
  11. name
    Aprile G
    type
    Author
  12. name
    Kulikov E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bang YJ
    type
    Author
  2. name
    Van Cutsem E
    type
    Author
  3. name
    Feyereislova A
    type
    Author
  4. name
    Chung HC
    type
    Author
  5. name
    Shen L
    type
    Author
  6. name
    Sawaki A
    type
    Author
  7. name
    Lordick F
    type
    Author
  8. name
    Ohtsu A
    type
    Author
  9. name
    Omuro Y
    type
    Author
  10. name
    Satoh T
    type
    Author
  11. name
    Aprile G
    type
    Author
  12. name
    Kulikov E
    type
    Author
bibliography ids
  1. nci-bib-c1d6eb555b4daf70a73de5c3
book metadata
content sha256
5d4a188a904772e6dedcaa2150227b596e65a616e66384582fb6c632609f1c3c
document type
citation
dois
  1. 10.1016/S0140-6736(10)61121-X
electronic publication date
display
2010 Aug 19
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20728210
immutable id
pubmed:20728210@5d4a188a904772e6dedcaa2150227b596e65a616e66384582fb6c632609f1c3c
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9742
name
Lancet (London, England)
nlm unique id
2985213R
pages
687-97
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2010 Oct 16;376(9749):1302
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2010 Aug 28;376(9742):659-60. doi: 10.1016/S0140-6736(10)61022-7.
    note
    Source null
    related pmid
    20728211
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2010 Nov;7(11):611. doi: 10.1038/nrclinonc.2010.161.
    note
    Source null
    related pmid
    21049571
    relationship
    Comment in
  4. citation
    Gastroenterology. 2011 Jan;140(1):356-8; discussion 358. doi: 10.1053/j.gastro.2010.11.011.
    note
    Source null
    related pmid
    21087674
    relationship
    Comment in
  5. citation
    Lancet. 2010 Nov 20;376(9754):1735; author reply 1735-6. doi: 10.1016/S0140-6736(10)62125-3.
    note
    Source null
    related pmid
    21093641
    relationship
    Comment in
  6. citation
    Biomark Med. 2010 Dec;4(6):793.
    note
    Source null
    related pmid
    21174864
    relationship
    Comment in
outcomes validated
false
pmid
20728210
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
f2f274814f94abf0566f3d8c36795c716f7d978d17e7df6d1db53698541c05c9
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Aug 28
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20728210/
title
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Preserved source evidence · Not medical advice